1. LB03A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT OR PLACEBO ON STANDARD OF CARE IN PATIENTS WITH ACTIVE CLASS III OR IV LUPUS NEPHRITIS. (28th May 2018) Authors: Jayne, David; Dooley, Mary; Wofsy, David; Takeuchi, Tsutomo; Malvar, Ana; Doria, Andrea; Romero-Díaz, Juanita; Chan, Tak; Elegbe, Ayanbola; Appel, Gerald; Furie, Richard; Maldonado, Michael Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Relationship Between Middle Ear Volume and Long-term Audiological Outcomes in Congenital Aural Atresia Repair. Issue 6 (July 2019) Authors: Imbery, Terence E.; Maldonado, Michael; Mukherjee, Sugoto; Kesser, Bradley W. Journal: Otology & neurotology Issue: Volume 40:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. "Green" electrospinning of a collagen/hydroxyapatite composite nanofibrous scaffold. (26th September 2016) Authors: Castilla-Casadiego, David A.; Maldonado, Michael; Sundaram, Paul; Almodovar, Jorge Journal: MRS communications Issue: Volume 6:Number 4(2016:Dec.) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Issue 1 (20th August 2013) Authors: Schiff, Michael; Weinblatt, Michael E; Valente, Robert; van der Heijde, Désirée; Citera, Gustavo; Elegbe, Ayanbola; Maldonado, Michael; Fleischmann, Roy Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 1(2014) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration. Issue 1 (19th April 2016) Authors: Schiff, Michael; Weinblatt, Michael E; Valente, Robert; Citera, Gustavo; Maldonado, Michael; Massarotti, Elena; Yazici, Yusuf; Fleischmann, Roy Journal: RMD open Issue: Volume 2:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study1. Issue 1 (27th December 2012) Authors: Weinblatt, Michael E.; Schiff, Michael; Valente, Robert; van der Heijde, Désirée; Citera, Gustavo; Zhao, Cathy; Maldonado, Michael; Fleischmann, Roy Journal: Arthritis and rheumatism Issue: Volume 65:Issue 1(2013:Jan.) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study. Issue 1 (27th December 2012) Authors: Weinblatt, Michael E.; Schiff, Michael; Valente, Robert; van der Heijde, Désirée; Citera, Gustavo; Zhao, Cathy; Maldonado, Michael; Fleischmann, Roy Journal: Arthritis and rheumatism Issue: Volume 65:Issue 1(2013:Jan.) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗